Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Teprotumumab N01
BIOLOGICAL
2 trials
Sponsors
Innovent Biologics (Suzhou) Co. Ltd.
, Sun Yat-sen University
Conditions
Graves Ophthalmopathy
Optic Neuropathy
Thyroid Eye Disease
Thyroid Eye Disease, TED
Phase 2
Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy
Not yet recruiting
NCT07594912
Sun Yat-sen University
Graves Ophthalmopathy, Optic Neuropathy, Thyroid Eye Disease, TED
Start: 2026-08-01
End: 2028-04-01
Target: 60
Updated: 2026-05-19
Phase 4
A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
Recruiting
NCT07265258
Innovent Biologics (Suzhou) Co. Ltd.
Thyroid Eye Disease
Start: 2026-07-30
End: 2028-12-30
Target: 92
Updated: 2026-08-13
Related Papers
Head-to-Head Comparison of an IGF-1R Inhibitor Versus Intravenous Glucocorticoid for Active Thyroid Eye Disease: Design of a Randomized Clinical Trial.
2026-07-14